#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2215305	ADME	Terminal half life in Sprague-Dawley rat at 5 mg/kg, po and 1 mg/kg, iv	Rattus norvegicus	2	ALA2202978	organism-based format	Scientific Literature
2.	ALA2215307	ADME	Oral bioavailability in Sprague-Dawley rat at 5 mg/kg	Rattus norvegicus	2	ALA2202978	organism-based format	Scientific Literature
3.	ALA2215309	ADME	Drug absorption in Sprague-Dawley rat portal vein at 5 mg/kg, po	Rattus norvegicus	2	ALA2202978	organism-based format	Scientific Literature
4.	ALA2215311	ADME	AUC (0 to infinity) in Sprague-Dawley rat at 5 mg/kg, po	Rattus norvegicus	2	ALA2202978	organism-based format	Scientific Literature
5.	ALA2215313	ADME	AUC in Sprague-Dawley rat at 1 mg/kg, iv	Rattus norvegicus	2	ALA2202978	organism-based format	Scientific Literature
6.	ALA2215315	ADME	Clearance in Sprague-Dawley rat at 1 mg/kg, iv	Rattus norvegicus	2	ALA2202978	organism-based format	Scientific Literature
7.	ALA2215317	Functional	Antiviral activity against HCV subtype 1b expressing NS3/4A R115K mutant protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
8.	ALA2215318	Functional	Antiviral activity against HCV subtype 1b expressing NS3/4A D168V mutant protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
9.	ALA2215319	Functional	Antiviral activity against HCV subtype 1b expressing NS3/4A D168A mutant protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
10.	ALA2215320	Functional	Antiviral activity against HCV subtype 1b expressing NS3/4A A156V mutant protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
11.	ALA2215321	Functional	Antiviral activity against HCV subtype 1b expressing NS3/4A A156T mutant protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
12.	ALA2215322	Functional	Antiviral activity against HCV subtype 1b expressing NS3/4A A156S mutant protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
13.	ALA2215323	Functional	Antiviral activity against HCV subtype 1b expressing wild type NS3/4A protease infected in ET cells after 72 hrs	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
14.	ALA2215324	Functional	Antiviral activity against HCV subtype 1b infected in human hepatoma cells	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
15.	ALA2215325	Functional	Antiviral activity against HCV subtype 1a infected in human hepatoma cells	Hepacivirus hominis	19	ALA2202978	organism-based format	Scientific Literature
16.	ALA2215774	Binding	Inhibition of HCV subtype 1a NS3/4A protease (Ac-DE-Dap(QXL520)-EE-Abu-psi-[COO]-ASC(5-FAMsp)-NH2 as substrate by FRET analysis	Hepatitis C virus subtype 1a	19	ALA2202978	assay format	Scientific Literature